$9M Shaved From Novartis Jaw Injury Award By NY Judge

Law360, New York (October 11, 2013, 6:37 PM ET) -- A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.’s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.

U.S. District Court Judge Arthur Spatt rejected Novartis's argument that a juror had improperly relied on external information in reaching the damage award in a November 2012 plaintiff's verdict by consulting the dictionary for a definition of the word “wanton,” saying those allegations are based on...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Davids et al v. Novartis Pharmaceuticals Corporation


Case Number

2:06-cv-00431

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Arthur D. Spatt

Date Filed

January 31, 2006

Law Firms

Companies

Government Agencies